JournalArta
Saturday, November 21, 2026 · JakartaS&P 6,910.39 ▼3.70%USD/IDR 18,158 ▼0.42%
JournalArta
Global Edition
beyond headlines
Advertisement

Bayer Wins Approval for $7.25 Billion Roundup Settlement

A Missouri judge has approved Bayer’s settlement of US lawsuits alleging that its Roundup weedkiller causes cancer. Payments to eligible participants will range from $10,000 to $165,000, with the company funding the agreement over as many as 21 years.

By Elena Vance
WIB2 min read
Bayer Wins Approval for $7.25 Billion Roundup Settlement
Bayer Wins Approval for $7.25 Billion Roundup Settlement

Bayer has won approval for a $7.25 billion settlement of US lawsuits alleging that its Roundup weedkiller causes cancer. A Missouri judge approved the agreement, which covers eligible users already diagnosed with non-Hodgkin lymphoma and those who develop it in the future.

The German company denies that Roundup causes cancer. It had faced approximately 65,000 claims in US state and federal courts from people who said they developed cancer after using the weedkiller at home or at work.

Payments and objections

Individual settlement payments range from $10,000 to $165,000. Amounts depend on how often participants used Roundup, when they were diagnosed and the severity of their illness.

Advertisement

Bayer will make annual payments into a fund for up to 21 years, providing as much as $7.25 billion. The agreement announced in February aimed to resolve nearly all current and future Roundup claims in the US.

Judge Timothy Boyer, of a state court in St. Louis, found the settlement “fair, reasonable, and adequate.” He overruled objections that individual payments would be too low because some claimants who settled earlier received more.

Boyer said further delay could force victims, including people with terminal cancer, to wait “an indeterminate number of years” for payment.

Some cases will continue. Bayer has said about 200 lawsuits excluded from the settlement were still being litigated in federal court.

Advertisement

Supreme Court ruling narrowed claims

The approval followed a US Supreme Court decision in June that overturned a $1.25 million jury award to Missouri resident John Durnell. He blamed years of exposure to Roundup’s active ingredient, glyphosate, for his non-Hodgkin lymphoma.

The court ruled 7-2 that a federal law regulating pesticides barred claims brought under state law over a failure to warn. Lawyer Christopher Seeger, who represents many plaintiffs, said the decision narrowed victims’ ability to pursue claims in court.

Bayer settled much of the Roundup litigation for $10.9 billion in 2020. It did not win court approval for a separate $1.25 billion settlement intended to resolve future claims.

Advertisement

Monsanto developed Roundup in the 1970s. Bayer bought Monsanto for $63 billion in 2018.

In 2015, the International Agency for Research on Cancer, a World Health Organization unit, identified glyphosate as a probable human carcinogen. Bayer and regulators including the US Environmental Protection Agency have disputed that finding.

Bayer has maintained that Roundup and glyphosate are safe, and that decades of studies showed glyphosate did not cause cancer.

Advertisement
What Kind of Holiday Spender Are You? Take the Black Friday QuizTake the quizWhat Kind of Holiday Spender Are You? Take the Black Friday QuizStart →
Advertisement
Most Read
  1. 1Stock Market Today: Dow Slides 1.34% and VIX Jumps 15% at MiddayStock Market Today: Dow Slides 1.34% and VIX Jumps 15% at Midday
  2. 2Joachim Klement to Sell Stocks After S&P 500 SignalJoachim Klement to Sell Stocks After S&P 500 Signal
  3. 3Stock Market Today: Nasdaq, S&P 500 Futures Slide as AI Selloff DeepensStock Market Today: Nasdaq, S&P 500 Futures Slide as AI Selloff Deepens
  4. 4Kenneth Walker’s Groin Injury Puts Cardinals Game in DoubtKenneth Walker’s Groin Injury Puts Cardinals Game in Doubt
  5. 5Pat Cummins Faces Captaincy Doubts From Mitchell JohnsonPat Cummins Faces Captaincy Doubts From Mitchell Johnson
Advertisement
Don't Miss

Latest News

All stories →
  1. Tilly Metz Calls for Fairer Access to Treatment Across EUWorld · EuropeTilly Metz Calls for Fairer Access to Treatment Across EUNov 21
  2. Moscow Rejects Kaja Kallas as Ukraine Peace NegotiatorWorld · EuropeMoscow Rejects Kaja Kallas as Ukraine Peace NegotiatorNov 21
  3. Amazon’s Black Friday Deals Include AirPods Pro 3 for $179Lifestyle · Shopping & DealsAmazon’s Black Friday Deals Include AirPods Pro 3 for $179Nov 21
  4. GTA 6 Has at Least Four Endings Shaped by Your ChoicesTechnology · GamingGTA 6 Has at Least Four Endings Shaped by Your ChoicesNov 21
  5. Advertisement
  6. Sunrise on the Reaping Earns Estimated $51 Million on First DayLifestyle · EntertainmentSunrise on the Reaping Earns Estimated $51 Million on First DayNov 21
  7. I Play Rocky Star P.J. Byrne Lands His Biggest Film RoleLifestyle · EntertainmentI Play Rocky Star P.J. Byrne Lands His Biggest Film RoleNov 21
  8. Chip Stocks Post Worst Week Since 2001 as Nasdaq SlidesMarkets · StocksChip Stocks Post Worst Week Since 2001 as Nasdaq SlidesNov 21
  9. Vodafone Stock Week Ahead (November 23–27): What Comes After a 7.35% Weekly LossMarkets · StocksVodafone Stock Week Ahead (November 23–27): What Comes After a 7.35% Weekly LossNov 21